Quantum BioPharma Submits IND for Lucid-MS Trial
TORONTO, April 1, 2026 Quantum BioPharma Ltd. announced the submission of an Investigational New Drug (IND) application to the...
GMP
Advertisement
InnoCan Secures FDA CVM Waiver for LPT-CBD Drug
HERZLIYA, Israel and CALGARY, Canada, February 27, 2026 InnoCan Pharma Corporation announced that the U.S. FDA Center for Veterinary...
MiNK Therapeutics Highlights Phase II iNKT Therapy at AACR
NEW YORK, April 3, 2026 MiNK Therapeutics announced that new Phase II clinical trial data for its investigational iNKT...
Thermo Fisher Launches Compleo System for Cell Therapy
WALTHAM, Mass., USA — April 2, 2026 Thermo Fisher Scientific Inc. has announced the global launch of the Gibco™...
AI Transforms Pharma R&D and Manufacturing Models
London, United Kingdom | March 23, 2026 The pharmaceutical industry is undergoing a profound transformation as artificial intelligence (AI),...
Advertisements
TriSalus Advances Tumor Drug Delivery With PEDD Tech
DENVER, USA – March 18, 2026 TriSalus Life Sciences has announced new preclinical findings demonstrating that its Pressure-Enabled Drug...
Marvel Secures Funding for Pediatric Liquid MB-204
Child-Friendly MB-204 Formulation Targets Neuro Disorders – February 18, 2026 | Calgary, Alberta Marvel Biosciences Corp. has secured advisory...
RSV Vaccine Data Show Reduced Cardio-Respiratory Risks
Real-World Evidence Strengthens Adult Prevention Impact February 17, 2026 | London, United Kingdom GSK has released new real-world effectiveness...
EU Clears ANKTIVA–BCG for Bladder Cancer Therapy
Conditional Approval Expands Access to 33 Countries February 18, 2026 | Culver City, California ImmunityBio announced that the European...
Elanco Sets Date for Q4 and Full-Year 2025 Results Call
Indianapolis, USA | January 22, 2026 — Elanco Animal Health, a global leader in veterinary pharmaceuticals and animal health...
Advertisement
